1Windecker S,Simon R,Lins M,et al.Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization the TiNOX trial[J].Circulation,2005,111:1 -6.
2Iakovou I,Schmidt T,Ge L,et al.Incidence and predictors of thrombosis after implantation of drug-eluting stents in unselected patients[J].ACC March,2005,6:1038-1039.
3Bhatt DL,Flather MD,Hacke W,et al.Patents with prior myocardial infarction,stroke,or symptomatic peripheral arterial disease in the CHARISMA trial[J].J Am Coll Cardio,2007,49:1982-1988.
4Gotman I.Characteristics of metals used in implants[J].J Endourol,1997,11:383-389.
5Hausleiter J, Kastrati A, Mehilli J, et al. Impact of lesion complexity on the capacity of a trial to detect differences in stent performance : results from the ISAR-STEREO trial [ J ]. Am Heart J, 2003, 146 (5) :882 -886.
6Brammer KS, Oh S, Gallagher JO, et al. Enhanced cellular mobility guided by TiO2 nanotube surfaces [ J ]. Nano Lett, 2008, 8 (3) :786 - 793.
7Lu J, Rao MP, MacDonald NC, et al. Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features [ J ]. Acta Biomater, 2008, 4(1) :192 -201
8Windecker S, Simon R, Lins M, et al. Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization : the TiNOX trial [ J ]. Circulation, 2005, 111(20) :2617 -2622.
9Karjalainen PP, Ylitalo A, Airaksinen JK. Titanium and nitride oxide-coated stent and paclitaxel-eluting stents for coronary revascu- larization in an unselected population [ J ]. J Invasive Cardiol, 2006, 18(10) :462 -468.
10Mosseri M, Tamari I, Plich M, et al. Short-and long-term outcomes of the titanium-NO stent registry[ J]. Cardiovasc Revasc Med, 2005, 6(1) :2 -6.
